A detailed history of Asb Consultores, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Asb Consultores, LLC holds 1,905 shares of MRK stock, worth $183,470. This represents 0.09% of its overall portfolio holdings.

Number of Shares
1,905
Previous 3,888 51.0%
Holding current value
$183,470
Previous $481,000 55.09%
% of portfolio
0.09%
Previous 0.17%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$111.15 - $128.97 $220,410 - $255,747
-1,983 Reduced 51.0%
1,905 $216,000
Q2 2024

Aug 12, 2024

SELL
$123.8 - $132.96 $199,565 - $214,331
-1,612 Reduced 29.31%
3,888 $481,000
Q1 2024

May 14, 2024

BUY
$113.24 - $131.95 $411,627 - $479,638
3,635 Added 194.91%
5,500 $725,000
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $162,091 - $176,394
-1,618 Reduced 46.45%
1,865 $203,000
Q3 2023

Nov 28, 2023

SELL
$102.95 - $114.33 $377,929 - $419,705
-3,671 Reduced 51.31%
3,483 $358,000
Q2 2023

Aug 07, 2023

SELL
$108.61 - $118.38 $34,320 - $37,408
-316 Reduced 4.23%
7,154 $825,000
Q1 2023

May 03, 2023

SELL
$102.94 - $114.86 $62,381 - $69,605
-606 Reduced 7.5%
7,470 $794,000
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $117,169 - $150,227
-1,340 Reduced 14.23%
8,076 $895,000
Q3 2022

Jan 11, 2023

BUY
$84.53 - $94.96 $137,276 - $154,215
1,624 Added 20.84%
9,416 $811,000
Q2 2022

Jan 11, 2023

SELL
$83.49 - $94.64 $195,700 - $221,836
-2,344 Reduced 23.13%
7,792 $710,000
Q1 2022

Jan 11, 2023

BUY
$73.51 - $82.4 $745,097 - $835,206
10,136 New
10,136 $832,000
Q4 2021

Jan 11, 2023

BUY
$72.28 - $90.54 $52,041 - $65,188
720 Added 7.65%
10,136 $777,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $244B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Asb Consultores, LLC Portfolio

Follow Asb Consultores, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asb Consultores, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asb Consultores, LLC with notifications on news.